Investors & Media

Nov 16, 2018 4:02 PM EST

Copyright Nasdaq. Minimum 15 minutes delayed.

Investors & Media

SEC Filing Details

SEC Filing Details

Document Details

Form
Filing Date
Nov 8, 2018
Document Date
Sep 30, 2018
Form Description
Quarterly report which provides a continuing view of a company's financial position
Filing Group
Quarterly Filings
Company
Keryx Biopharmaceuticals, Inc.
Issuer
KERYX BIOPHARMACEUTICALS INC